Plain Language Summaries Becoming A Mandate Worldwide
At first glance, the creation of plain language summaries (PLS) may seem straightforward. However, a closer look reveals that PLS requires a meticulous multi-step process, including planning, development, translation, and dissemination. While the term “plain language summary” is generally favored in the industry over “lay summary,” these four key steps are based on the European Health Union’s Good Lay Summary Practice guidance issued in 2021.
Experts thoroughly discussed these considerations at the annual TrialScope EXTRA customer event in New York City, which focuses on all aspects of clinical trial disclosure. The event highlighted the complexities and best practices in creating effective PLS, underscoring the importance in enhancing transparency and understanding of clinical trial results for broader audiences.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.